CXCR4-MOR Bivalent Ligand
Invented at Virginia Commonwealth University
- Datasheet
- References (0)
- Inventor Info
Info
Catalogue Number | 154267 |
Antigen/Gene or Protein Targets | mu opioid receptor and C-X-C chemokine receptor 4 |
Relevance | A novel bivalent ligand that contains two distinct pharmacophores linked through a spacer, one of which will interact with the mu opioid receptor (MOR) and the other with CXCr4. Naltrexone and It1t were selected as the pharmacophores to generate the bivalent probe. |
Research Area | Cell Signaling & Signal Transduction, Drug Discovery & Development |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference